Rysz Jacek, Franczyk Beata, Ławiński Janusz, Gluba-Brzózka Anna
Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, 90-419 Łódź, Poland.
Department of Urology, Institute of Medical Sciences, Medical College of Rzeszow University, 35-959 Rzeszow, Poland.
Antioxidants (Basel). 2020 Nov 3;9(11):1079. doi: 10.3390/antiox9111079.
Chronic kidney disease is highly prevalent worldwide. The decline of renal function is associated with inadequate removal of a variety of uremic toxins that exert detrimental effects on cells functioning, thus affecting the cardiovascular system. The occurrence of cardiovascular aberrations in CKD is related to the impact of traditional risk factors and non-traditional CKD-associated risk factors, including anemia; inflammation; oxidative stress; the presence of some uremic toxins; and factors related to the type, frequency of dialysis and the composition of dialysis fluid. Cardiovascular diseases are the most frequent cause for the deaths of patients with all stages of renal failure. The kidney is one of the vital sources of antioxidant enzymes, therefore, the impairment of this organ is associated with decreased levels of these enzymes as well as increased levels of pro-oxidants. Uremic toxins have been shown to play a vital role in the onset of oxidative stress. Hemodialysis itself also enhances oxidative stress. Elevated oxidative stress has been demonstrated to be strictly related to kidney and cardiac damage as it aggravates kidney dysfunction and induces cardiac hypertrophy. Antioxidant therapies may prove to be beneficial since they can decrease oxidative stress, reduce uremic cardiovascular toxicity and improve survival.
慢性肾脏病在全球范围内高度流行。肾功能下降与多种尿毒症毒素清除不足有关,这些毒素对细胞功能产生有害影响,进而影响心血管系统。慢性肾脏病中心血管异常的发生与传统危险因素以及与慢性肾脏病相关的非传统危险因素的影响有关,包括贫血、炎症、氧化应激、某些尿毒症毒素的存在,以及与透析类型、频率和透析液成分相关的因素。心血管疾病是所有阶段肾衰竭患者死亡的最常见原因。肾脏是抗氧化酶的重要来源之一,因此,该器官的损伤与这些酶水平的降低以及促氧化剂水平的升高有关。尿毒症毒素已被证明在氧化应激的发生中起重要作用。血液透析本身也会增强氧化应激。氧化应激升高已被证明与肾脏和心脏损伤密切相关,因为它会加重肾功能障碍并诱发心脏肥大。抗氧化疗法可能被证明是有益的,因为它们可以降低氧化应激、减少尿毒症心血管毒性并提高生存率。